Research programme: wnt signalling pathway modulators - RenovoAlternative Names: RN 1005
Latest Information Update: 08 Jun 2011
At a glance
- Originator Renovo
- Class Wnt proteins
- Mechanism of Action Wnt signalling pathway modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- Available For Licensing Yes
Highest Development Phases
- Discontinued Scars